Eco-Friendly Analytical quality by design approach stability-indicating HPTLC technique for the quantitative evaluation of fluoxetine

Year 2023, Volume: 27 Issue: 1, 274 - 289, 28.06.2025

Durgadevi Perumal Manikandan K , Lakshmi Karunanidhi Santhana

Abstract

A design of experiments (DoE)-based quality by design (QbD) method was used to develop a stability-indexing assay method in high performance thin layer chromatography (HPTLC) for the kinetic study of fluoxetine. This research proposes to use an environmentally friendly HPTLC technique based on Analytical Quality by Design (AQbD) to determine environmental friendliness. According to the literature, there is currently no published article on this method. A stationary phase consisting of TLC plates (Merck) pre-coated with silica gel 60F254 on aluminum sheets was used. A mobile phase of acetone: water with 1% orthophosphoric acid (8.5:1.5 v/v) was used. Central Composite Design (CCD) provides the opportunity to optimize the HPTLC separation and determine the parameters that have the greatest influence and those that have interactions. 20 optimized experimental runs were performed, including organic solvent content (A), saturation time (B), and driving distance (C). These 3 factors were evaluated for robustness, showing an insignificant effect on retention. The Rf value was 0.72±0.07, and the calibration curves were linear in the range of 0.3-5 mcg/point with regression coefficients r2 of 0.9987 for fluoxetine HCl. In the intraday and interday precision study, the percent RSD was 0.26 and 0.28, respectively. Fluoxetine was found to be highly susceptible to alkaline and acid hydrolysis compared to oxidation. All system suitability parameters were validated and were within the range specified in ICH guidelines. The novel method was also evaluated using four different approaches, including other evaluation methods: NEMI, GAPI, AGMS, AGREE, and it was found to be environmentally friendly.

Keywords

Design of the experiment , HPTLC; Green analytical chemistry , Stability-Indicating Assay method , Validation

References

• 1] M.Y. Guo, M. Etminan, R.M. Procyshyn, D.D. Kim, A. Samii, A. Kezouh, B.C. Carleton, Association of Antidepressant Use with Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study, Journal of Clinical Psychopharmacology. 38 (2018) 349–356. [CrossRef]
• [2] APA, The Treatment of Depression Across Three Age Cohorts, (2019). [CrossRef]
• [3] B. Matthews, Regulatory Aspects of Stability Testing in Europe, 25 (2000) 579–618.[CrossRef]
• [4] V.R. Sinha, Monika, A. Trehan, M. Kumar, S. Singh, J.R. Bhinge, Stress studies on acyclovir, Journal of Chromatographic Science. 45 (2007) 319–324. [CrossRef]
• [5] ICH, Ich Q1B, Stability Testing : Photostability Testing of New Drug Substances and Drug Products. (1996). [6] K.K. Pradhan, Mukhopadhyay et al 1995.pdf, 5 (2014) 3418–3424. [CrossRef]
• [7] R.S. Kumar, P. Gayathri, N. Duganath, C. Kiran, C. Sridhar, K. Jayaveera, Simultaneous estimation of fluoxetine HCl and olanzapine in bulk Drug and pharmaceutical formulation by using UV-Visible spectroscopy method, International Journal of Pharmaceutical Sciences and Drug Research. 3 (2011) 52–55.
• [8] A. Kumar, S.K. Jain, Development and Validation of UV-Spectroscopy Based Stability Indicating Method for the Determination of Fluoxetine Hydrochloride, Analytical Chemistry Letters. 6 (2016) 894–902. [CrossRef]
• [9] A. Pathak, S.J. Rajput, Development of a stability-indicating HPLC method for simultaneous determination of olanzapine and fluoxetine in combined dosage forms, Journal of Chromatographic Science. 47 (2009) 605–611. [CrossRef]
• [10] M.M. Eswarudu, M. Anitha, N. Gayathri, T. Chaithanya, a Validated Rp-Hplc Method for the Simultaneous Estimation of Fluoxetine Hydrochloride and Olanzapine in Pharmaceutical Dosage Form, International Research Journal of Pharmacy. 3 (2012) 310–313.
• [11] O.F. Fluoxetine, L. Chromatography, B.Y. High-, Laboratory Medicine, University of Connecticut School qf Medicine, 499 (1990) 601–608.
• [12] G. Swapna, S.A. Rahaman, A.P. Rani, Development and validation of stability indicating analytical method for simultaneous estimation of cilnidipine, chlorthalidone and telmisartan in bulk and tablet dosage form, Indian Drugs. 57 (2020) 51–55. [CrossRef]
• [13] N. Yilmaz, Y. Özkan, S.A. Özkan, I. Biryol, H.Y. Aboul-Enein, High performance liquid chromatographic assay and drug dissolution studies of fluoxetine hydrochloride in capsule formulations, Journal of Liquid Chromatography and Related Technologies. 23 (2000) 1699–1710. [CrossRef]
• [14] A.A. Wassel, Development and Validation of (HPLC) Method for Simultaneous Determination of Atomoxetine HCl & Fluoxetine HCl in their Pharmaceutical Dosage Forms, Biomedical Journal of Scientific & Technical Research. 34 (2021) 26943–26950. [CrossRef]
• [15] C. Shah, B. Suhagia, N. Shah, D. Patel, N. Patel, Stability-indicating simultaneous HPTLC method for olanzapine and fluoxetine in combined tablet dosage form, Indian Journal of Pharmaceutical Sciences. 70 (2008) 251–255. [CrossRef]
• [16] M. Jagadeeswaran, S. Mahibalan, N. Gopal, Estimation of fluoxetine in capsule dosage form by HPTLC method, International Journal of Pharmacy and Pharmaceutical Sciences. (2009) 71–73.
• [17] Z. Zaheer, O. Shaikh, S. Thorat, R. Ahmed, Development and Validation of HPTLC Method of Fluoxetine Hydrochloride in Bulk and Pharmaceutical Formulation, 2 (2010) 44–48.
• [18] D. Shankar Maruti, S. Kumar Banerjee, Development and validation of HPTLC method for estimation of acyclovir in formulations, International Journal of Research in Pharmaceutical Sciences. 4 (2013) 310–315.
• [19] A. Maalanka, U. Hubicka, J. Krzek, M. Walczak, G. Izworski, Determination of fluoxetine in the presence of photodegradation products appearing during UVA irradiation in a solid phase by chromatographic- densitometric method, kinetics and identification of photoproducts, Acta Chromatographica. 25 (2013) 465–481. [CrossRef]
• [20] A.B. Thomas, A. Naphade, S.S. Karanjkhele, Determination of alprazolam and fluoxetine HCL from spiked rat plasma using HPTLC with UV detection, International Journal of Pharmacy and Pharmaceutical Sciences. 8 (2016) 147–151.
• [21] S. Mennickent, R. Fierro, M. Vega, M. De Diego, C.G. Godoy, Quantitative determination of fluoxetine in human serum by high performance thin layer chromatography, Journal of Separation Science. 33 (2010) 2206–2210. [CrossRef]
• [22] H.F. Books, D. References, M. Windows, Design – Expert, (1996) 10–12. [23] S.L.C. Ferreira, R.E. Bruns, H.S. Ferreira, G.D. Matos, J.M. David, G.C. Brand, E.G.P. Silva, P.S. Reis, A.S. Souza, W.N.L. Santos, Box-Behnken design : An alternative for the optimization of analytical methods, 597 (2007) 179–186. [CrossRef]
• [24] M. Almeida, R. Erthal, E. Padua, L. Silveira, L. Am, Talanta Response surface methodology ( RSM ) as a tool for optimization in analytical chemistry, 76 (2008) 965–977. [CrossRef]
• [25] A. Gundala, K. Prasad, B. Koganti, Application of quality by design approach in RP-HPLC method development for simultaneous estimation of saxagliptin and dapagliflozin in tablet dosage form, (2015) 1–10. [26] International Conference, O.N. Harmonisation, O.F. Technical, R. For, R. Of, P. For, A. Of, requırements for regıstratıon of pharmaceutıcals for human ıch h armonısed t rıpartıte g uıdelıne v alıdatıon of analytıcal p rocedures : Parent Guideline : Text on Validation of Analytical Procedures, 1994 (2005). [27] C.M. Thompson, L.C. Haws, M.A. Harris, N.M. Gatto, D.M. Proctor, Application of the U.S. EPA mode of action framework for purposes of guiding future research: A case study involving the oral carcinogenicity of hexavalent chromium, Toxicological Sciences. 119 (2011) 20–40. [CrossRef]
• [28] EPA, Managing Your Hazardous Waste, Marine Pollution Bulletin. 11 (2001) 31.
• [29] B. Systems, S. Occupancies, H. Materials, Fire Code, 1 (2021) 2021–2022.
• [30] J. Płotka-Wasylka, A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index, Talanta. 181 (2018) 204–209. [CrossRef]
• [31] H.M. Mohamed, N.T. Lamie, Analytical eco-scale for assessing the greenness of a developed RP-HPLC method used for simultaneous analysis of combined antihypertensive medications, Journal of AOAC International. 99 (2016) 1260–1265. [CrossRef]
• [32] L.J. Diorazio, P. Richardson, H.F. Sneddon, A. Moores, C. Briddell, I. Martinez, Making Sustainability Assessment Accessible: Tools Developed by the ACS Green Chemistry Institute Pharmaceutical Roundtable, ACS Sustainable Chemistry and Engineering. 9 (2021) 16862–16864. [CrossRef]
• [33] F. Pena-Pereira, W. Wojnowski, M. Tobiszewski, AGREE - Analytical GREEnness Metric Approach and Software, Analytical Chemistry. 92 (2020) 10076–10082. [CrossRef]
• [34] K.S. Kokilambigai, K.S. Lakshmi, Utilization of green analytical chemistry principles for the simultaneous estimation of paracetamol, aceclofenac and thiocolchicoside by UV spectrophotometry, Green Chemistry Letters and Reviews. 14 (2021) 97–105. [CrossRef]
• [35] H.K. Chanduluru, A. Sugumaran, Eco-friendly estimation of isosorbide dinitrate and hydralazine hydrochloride using Green Analytical Quality by Design-based UPLC Method, RSC Advances. 11 (2021) 27820–27831. [CrossRef]